Literature DB >> 19338766

Hyaluronan inhibits bone resorption by suppressing prostaglandin E synthesis in osteoblasts treated with interleukin-1.

Michiko Hirata1, Megumi Kobayashi, Morichika Takita, Chiho Matsumoto, Chisato Miyaura, Masaki Inada.   

Abstract

Hyaluronan (HA), a large glycosaminoglycan, is a component of the extra-cellular matrix in various tissues. HA is essential for matrix assembly and fluid viscosity in cartilage, but the roles of HA in bone are unclear. Bone resorption associated with inflammation is closely related to prostaglandin E (PGE) synthesis by osteoblasts induced by cytokines such as interleukin-1 (IL-1). In mouse calvarial cultures, HA inhibited osteoclastic bone resorption and PGE production induced by IL-1. In mouse osteoblasts, HA suppressed IL-1-induced expression of cyclooxygenase(COX)-2 and membrane-bound PGE synthase (mPGES)-1 mRNAs, and PGE2 production. Matrix metalloproteinases (MMPs), including MMP-2 and MMP-13, were produced by osteoblasts in response to IL-1, and were clearly suppressed by HA. In osteoblasts, HA suppressed the NFkappaB-dependent transcription in a luciferase assay. Therefore, HA acts on osteoblasts to suppress the production of PGE2 and MMPs, and inhibits bone resorption, suggesting critical roles of HA in pathological bone loss with inflammation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19338766     DOI: 10.1016/j.bbrc.2009.01.146

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Hierarchical organization of osteoblasts reveals the significant role of CD166 in hematopoietic stem cell maintenance and function.

Authors:  Brahmananda R Chitteti; Ying-Hua Cheng; Melissa A Kacena; Edward F Srour
Journal:  Bone       Date:  2013-01-28       Impact factor: 4.398

2.  Correlation Between Serum 25(OH)D and Abdominal Visceral Fat Area in Patients with Type 2 Diabetes Mellitus in the Context of different Bone Mass.

Authors:  Q Li; Y Zhao; Y P Wang; Y Yang; S M He; X Zhang; Z Wang; L Y Luo
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Jul-Sep       Impact factor: 1.104

3.  Reactive oxygen species induce Cox-2 expression via TAK1 activation in synovial fibroblast cells.

Authors:  Yuta Onodera; Takeshi Teramura; Toshiyuki Takehara; Kanae Shigi; Kanji Fukuda
Journal:  FEBS Open Bio       Date:  2015-06-06       Impact factor: 2.693

4.  Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.

Authors:  Anna Kats; Maria Norgård; Zenebech Wondimu; Catalin Koro; Hernán Concha Quezada; Göran Andersson; Tülay Yucel-Lindberg
Journal:  J Cell Mol Med       Date:  2016-03-14       Impact factor: 5.310

5.  Effects of Polymethoxyflavonoids on Bone Loss Induced by Estrogen Deficiency and by LPS-Dependent Inflammation in Mice.

Authors:  Shigeru Matsumoto; Tsukasa Tominari; Chiho Matsumoto; Shosei Yoshinouchi; Ryota Ichimaru; Kenta Watanabe; Michiko Hirata; Florian M W Grundler; Chisato Miyaura; Masaki Inada
Journal:  Pharmaceuticals (Basel)       Date:  2018-01-20

6.  Effects of O-methylated (-)-epigallocatechin gallate (EGCG) on LPS-induced osteoclastogenesis, bone resorption, and alveolar bone loss in mice.

Authors:  Tsukasa Tominari; Ryota Ichimaru; Shosei Yoshinouchi; Chiho Matsumoto; Kenta Watanabe; Michiko Hirata; Florian M W Grundler; Masaki Inada; Chisato Miyaura
Journal:  FEBS Open Bio       Date:  2017-11-15       Impact factor: 2.693

7.  Gram-positive bacteria cell wall-derived lipoteichoic acid induces inflammatory alveolar bone loss through prostaglandin E production in osteoblasts.

Authors:  Tsukasa Tominari; Ayumi Sanada; Ryota Ichimaru; Chiho Matsumoto; Michiko Hirata; Yoshifumi Itoh; Yukihiro Numabe; Chisato Miyaura; Masaki Inada
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

8.  Osteocytic connexin 43 is not required for the increase in bone mass induced by intermittent PTH administration in male mice.

Authors:  R Pacheco-Costa; H M Davis; E G Atkinson; E Katchburian; L I Plotkin; R D Reginato
Journal:  J Musculoskelet Neuronal Interact       Date:  2016-03       Impact factor: 2.041

Review 9.  Review of the Mechanism of Action for Supartz FX in Knee Osteoarthritis.

Authors:  Roy D Altman; Vinod Dasa; Jun Takeuchi
Journal:  Cartilage       Date:  2016-12-29       Impact factor: 4.634

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.